loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 22522 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ASTRAZENECA (2)

filter

01 TABLET;ORAL (2)

filter

01 RX (2)

filter

01 DALIRESP (2)

filter

01 Yes (2)

URL Supplier Web Content
TABLET; ORAL
250MCG
2018-01-23
22522
DALIRESP
RX
Yes
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
500MCG
2011-02-28
22522
DALIRESP
RX
Yes
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 22522

Looking for FDA Orange Book APPLICATION 22522 2

19

AstraZeneca, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ROFLUMILAST, with a corresponding application number 22522.

Regulatory Information RX

With a dosage strength 250MCG

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2018-01-23

Therapeutic Equivalence (TE) Code AB

18

AstraZeneca, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ROFLUMILAST, with a corresponding application number 22522.

Regulatory Information RX

With a dosage strength 500MCG

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2011-02-28

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY